Kortex Ventures
Overview
Kortex Ventures is a Brazilian corporate venture capital firm that invests in early-stage companies focused on healthtech, digital health, and personalized medicine. The firm is backed by diagnostics services providers Fleury and Sabin, and health insurer Bradesco Saude.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Huna | Jun 2025 | Pre Seed | Lead |
| Sweetch | Jul 2021 | Series A | Co-investor |
| Biologix | May 2024 | Seed | Lead |
| Carol | Jan 2026 | Series A | Co-investor |
| Caveo | Dec 2025 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Gabriel Costa
Venture Partner, Investment Commitee Member
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kortex Ventures based?
Kortex Ventures is headquartered in São Paulo, Brazil.
When was Kortex Ventures founded?
Kortex Ventures was founded in 2020.
How many portfolio companies does Kortex Ventures have?
Kortex Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Kortex Ventures's portfolio?
Portfolio companies visible on Caplight include Huna, Sweetch, Biologix, Carol, Caveo.
What was Kortex Ventures's most recent investment shown here?
Kortex Ventures's most recent investment in this portfolio sample was in Carol in 2026.
What sectors does Kortex Ventures focus on?
Kortex Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does Kortex Ventures focus on?
Kortex Ventures typically invests at the Early stage.
What is Kortex Ventures's AUM?
Kortex Ventures's assets under management are estimated between $40.0M and $50.0M.